5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis.

      The EMBO Journal
      Animals, Antigens, CD95, genetics, physiology, Apoptosis, immunology, Autoimmunity, Base Sequence, Cell Line, DNA Primers, Gene Expression, Humans, Lymphatic Diseases, etiology, Lymphocyte Activation, Lymphocytes, cytology, Mice, Mice, Transgenic, Molecular Sequence Data, Proto-Oncogene Proteins, Proto-Oncogene Proteins c-bcl-2, Proto-Oncogenes, Serpins, Signal Transduction, T-Lymphocytes, Viral Proteins

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Activation of the cell surface receptor Fas/APO-1 (CD95) induces apoptosis in lymphocytes and regulates immune responses. The cytoplasmic membrane protein Bcl-2 inhibits lymphocyte killing by diverse cytotoxic agents, but we found it provided little protection against Fas/APO-1-transduced apoptosis in B lymphoid cell lines, thymocytes and activated T cells. In contrast, the cowpox virus protease inhibitor CrmA blocked Fas/APO-1-transduced apoptosis, but did not affect cell death induced by gamma-radiation or serum deprivation. Signalling through Fas/APO-1 did not down-regulate Bcl-2 or induce its antagonists Bax and Bcl-xS. In Fas/APO-1-deficient lpr mice, Bcl-2 transgenes markedly augmented the survival of antigen-activated T cells and the abnormal accumulation of lymphocytes (although they did not interfere with deletion of auto-reactive cells in the thymus). These data raise the possibility that Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis.

          Related collections

          Author and article information

          Comments

          Comment on this article